PriorPath: Coarse-To-Fine Approach for Controlled De-Novo Pathology Semantic Masks Generation
View abstract on PubMed
Summary
This summary is machine-generated.PriorPath generates realistic synthetic histopathological images with controlled cellular features for artificial intelligence (AI) in digital pathology. This method overcomes data bias by creating diverse, high-fidelity images for improved AI model training and diagnostics.
Area Of Science
- Digital pathology
- Computational pathology
- Artificial intelligence in medicine
Background
- Digital pathology leverages artificial intelligence (AI) for enhanced image analysis and diagnostics.
- Biased datasets due to tissue diversity and labeling limitations hinder AI applicability.
- Existing methods for synthetic histopathological image generation suffer from mode collapse, failing to capture data diversity.
Purpose Of The Study
- To introduce PriorPath, a novel pipeline for generating controllable, realistic semantic masks and synthetic histopathological images.
- To address the limitations of existing generative models in capturing data diversity and controlling cellular characteristics.
Main Methods
- PriorPath generates detailed semantic masks from coarse-grained tissue images, enabling control over spatial distribution.
- The pipeline uses these masks as priors for conditional generative approaches to create photorealistic synthetic images.
- The method was validated across skin, prostate, and lung cancer datasets.
Main Results
- PriorPath effectively covers the semantic mask space, outperforming previous methods in similarity to real masks.
- The approach allows for precise control over tissue distributions in generated synthetic images.
- Demonstrated efficacy across three distinct cancer types (skin, prostate, lung).
Conclusions
- PriorPath offers a state-of-the-art, controllable solution for generating synthetic histopathological images.
- This facilitates the creation of robust, unbiased AI models for computational pathology.
- Enables advancements in clinical decision support, diagnostics, and early cancer detection.

